Emergence of Carbapenem Non-susceptible Campylobacter coli after Long-term Treatment against Recurrent Bacteremia in a Patient with X-linked Agammaglobulinemia.

Hagiya, Hideharu; Kimura, Keigo; Nishi, Isao; Yoshida, Hisao; Yamamoto, Norihisa; Akeda, Yukihiro; Tomono, Kazunori

Hagiya, Hideharu; Kimura, Keigo; Nishi, Isao; Yoshida, Hisao; Yamamoto, Norihisa; Akeda, Yukihiro; Tomono, Kazunori.

Afiliación

Hagiya H; Division of Infection Control and Prevention, Osaka University Hospital, Japan.
Kimura K; Laboratory for Clinical Investigation, Osaka University Hospital, Japan.
Nishi I; Laboratory for Clinical Investigation, Osaka University Hospital, Japan.
Yoshida H; Division of Infection Control and Prevention, Osaka University Hospital, Japan.
Yamamoto N; Department of Pediatrics, Osaka University Hospital, Japan.
Akeda Y; Division of Infection Control and Prevention, Osaka University Hospital, Japan.
Tomono K; Division of Infection Control and Prevention, Osaka University Hospital, Japan.

Intern Med ; 57(14): 2077-2080, 2018 Jul 15.

Article en En | MEDLINE | ID: mdl-29491300

Asunto(s)

Infecciones por Campylobacter/tratamiento farmacológico; Campylobacter coli; Carbapenémicos/farmacología; Farmacorresistencia Bacteriana/efectos de los fármacos; Adulto; Agammaglobulinemia; Antibacterianos/farmacología; Antibacterianos/uso terapéutico; Bacteriemia/tratamiento farmacológico; Carbapenémicos/uso terapéutico; Enfermedades Genéticas Ligadas al Cromosoma X; Humanos; Infusiones Intravenosas; Cuidados a Largo Plazo; Masculino

Palabras clave

Campylobacter coli; bacteremia; carbapenem; faropenem; soft tissue infection; tebipenem

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por Campylobacter / Carbapenémicos / Campylobacter coli / Farmacorresistencia Bacteriana Idioma: En Revista: Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google